Bioventus Inc. (NASDAQ:BVS) Q1 2024 Earnings Call Transcript
Bioventus Inc. beats earnings expectations. Reported EPS is $0.07, expectations were $-0.05. Bioventus Inc.
Bioventus Inc. (BVS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Juniper Investment Company Alexis Michas And John Bartholdson | 6,833,857 | $35,536,056 | 17.68% | |
| 2. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 5,806,012 | $30,191,262 | -3% | 1.72% |
| 3. | Millennium Management Israel Englander | 549,432 | $2,857,046 | +134% | 0% |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 240,448 | $1,250,330 | +27% | 0% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 141,232 | $734,406 | +11% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.14 | 26,595 | Officer, Director | 26,595 | 2023-08-18 | Filing | |
| $4.14 | 13,290 | Officer, Director | 138,290 | 2023-08-18 | Filing | |
| $4.79 | 14,985 | Large Shareholder, Director | 6,833,857 | 2023-08-14 | Filing | |
| $4.60 | 50,037 | Large Shareholder, Director | 6,818,872 | 2023-08-11 | Filing | |
| $4.79 | 14,985 | 6,833,857 | 2023-08-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.57 | 9,219 | Officer | 84,895 | 2024-06-21 | Filing | |
| $5.57 | 5,904 | Officer | 95,576 | 2024-06-21 | Filing | |
| $5.57 | 2,559 | Officer | 41,199 | 2024-06-21 | Filing | |
| $5.84 | 13,753 | Officer | 63,114 | 2024-06-17 | Filing | |
| $5.84 | 11,308 | Officer | 81,630 | 2024-06-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,021,324 | $68,622,377 | 16.98% | |
| 2. | 1,218,500 | $6,421,495 | 0% | |
| 3. | 505,574 | $2,664,375 | 0% | |
| 4. | 407,444 | $2,147,635 | 0% | |
| 5. | 363,804 | $1,917,247 | 0.04% |
News See All
Bioventus Inc. (NASDAQ:BVS) Q4 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Bioventus Inc. Fourth Quarter 2023 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Bioventus Inc. (NASDAQ:BVS) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. My name is Dustin, and I will be your conference operator today. This time, I would like to welcome everyone to Bioventus Inc.
Bioventus Inc. (NASDAQ:BVS) Q2 2023 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to Bioventus, Inc. Second Quarter 2023 Earnings Conference Call. I will now turn the call over to your host for today, Mr.
Hedge Fund and Insider Trading News: Cathie Wood, Chase Coleman, Lansdowne Partners, Miller Value Partners, Metacapital Management, Picton Mahoney Asset Management, Nordea Asset Management, Boston Properties, Inc. (BXP), Barnwell Industries, Inc. (BRN), and More
London-based investment manager Lansdowne Partners LLP said on Wednesday it had agreed to acquire the $1.1 billion UK equities manager CRUX Asset Management, subject to regulatory approval, according ...
Bioventus Inc. (NASDAQ:BVS) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Bioventus Inc. First Quarter 2023 Earnings Conference Call.
Bioventus Inc. (NASDAQ:BVS) Q4 2022 Earnings Call Transcript
Operator: Good day. And welcome to the Bioventus Incorporated Fourth Quarter 2022 Earnings Conference Call. All participants will be in a listen-only mode.
Here’s Why Bioventus (BVS) Declined in Q4
Wasatch Global Investors, an asset management company, released its “Wasatch Micro Cap Value Strategy” fourth-quarter 2022 investor letter. A copy of the same can be downloaded here.
15 Largest Orthopedic Companies in the World
The orthopedic industry has staged a comeback in the last two years following a dismal 2020 due to the lockdowns and restrictions during the COVID-19 pandemic.
Top 11 Stocks With Growth Potential According to Juniper Investment Company
In this article, we present the list of top 11 stocks with growth potential according to Juniper Investment Company.
Billionaire Hedge Funds
